Literature DB >> 19059669

An approaching genetic algorithm for automatic beam angle selection in IMRT planning.

Jie Lei1, Yongjie Li.   

Abstract

A method named approaching genetic algorithm (AGA) is introduced to automatically select the beam angles for intensity-modulated radiotherapy (IMRT) planning. In AGA, the best individual of the current population is found at first, and the rest of the normal individuals approach the current best one according to some specially designed rules. In the course of approaching, some better individuals may be obtained. Then, the current best individual is updated to try to approach the real best one. The approaching and updating operations of AGA replace the selection, crossover and mutation operations of the genetic algorithm (GA) completely. Using the specially designed updating strategies, AGA can recover the varieties of the population to a certain extent and retain the powerful ability of evolution, compared to GA. The beam angles are selected using AGA, followed by a beam intensity map optimization using conjugate gradient (CG). A simulated case and a clinical case with nasopharynx cancer are employed to demonstrate the feasibility of AGA. For the case investigated, AGA was feasible for the beam angle optimization (BAO) problem in IMRT planning and converged faster than GA.

Entities:  

Mesh:

Year:  2008        PMID: 19059669     DOI: 10.1016/j.cmpb.2008.10.005

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  2 in total

1.  Optimization of beam angles for intensity modulated radiation therapy treatment planning using genetic algorithm on a distributed computing platform.

Authors:  Daryl P Nazareth; Stephen Brunner; Matthew D Jones; Harish K Malhotra; Mohammad Bakhtiari
Journal:  J Med Phys       Date:  2009-07

2.  A matter of timing: identifying significant multi-dose radiotherapy improvements by numerical simulation and genetic algorithm search.

Authors:  Simon D Angus; Monika Joanna Piotrowska
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.